These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6110219)

  • 1. Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.
    Rastogi RB; Singhal RL; Lapierre YD
    Psychopharmacology (Berl); 1980; 72(1):85-91. PubMed ID: 6110219
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotropin releasing hormone potentiates the effects of imipramine on brain serotonergic system.
    Rastogi RB; Singhal RL; Lapierre YD
    Brain Res Bull; 1981 Oct; 7(4):449-51. PubMed ID: 6170395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-771 enhances the turnover of norepinephrine in brain.
    Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):187-90. PubMed ID: 6115460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone--increased catabolism of catecholamines in brains of thyroidectomized rats.
    Marek K; Haubrich DR
    Biochem Pharmacol; 1977 Oct; 26(19):1817-8. PubMed ID: 410420
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 7. A possible mechanism for the anti-depressant activity of thyrotropin releasing hormone.
    Horst WD; Spirt N
    Life Sci; 1974 Sep; 15(6):1073-82. PubMed ID: 4157277
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of tyrosine on brain catecholamine turnover in reserpine-treated rats.
    Oishi T; Wurtman RJ
    J Neural Transm; 1982; 53(2-3):101-8. PubMed ID: 7077311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine potentiates imipramine-induced effects on catecholamine metabolism: possible relation to antidepressant activity.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Popik P; Krawczyk M; Nalepa I; Vetulani J
    Pharmacol Rep; 2006; 58(6):836-45. PubMed ID: 17220541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Involvement of tyrosine hydroxylase in functional characteristics of discrete brain nuclei].
    Nakahara T; Uchimura H; Hirano M
    Yakubutsu Seishin Kodo; 1987 Dec; 7(4):453-61. PubMed ID: 2898187
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclazocine and norepinephrine uptake, metabolism, and turnover in the rat brain.
    Russi GD
    J Pharm Sci; 1985 Jan; 74(1):97-9. PubMed ID: 3981430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].
    Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I
    Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 15. Concentrations of striatal catecholamines in rats given manganese chloride through drinking water.
    Chandra SV; Shukla GS
    J Neurochem; 1981 Feb; 36(2):683-7. PubMed ID: 7463083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptosomal uptake of norepinephrine and 5-hydroxytryptamine and synthesis of catecholamines during benzodiazepine treatment.
    Rastogi RB; Lapierre YD; Singhal RL
    Can J Physiol Pharmacol; 1978 Oct; 56(5):777-84. PubMed ID: 30525
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo.
    Kreutz MR; Acworth IN; Lehnert H; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):347-52. PubMed ID: 1707722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
    Pawlowski L; Nowak G; Górka Z; Mazela H
    Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central monoamine metabolism in depressions. II. Catecholamines and related compounds.
    van Praag HM
    Compr Psychiatry; 1980; 21(1):44-54. PubMed ID: 6987035
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute pancreatitis affects the metabolism of catecholamine neurotransmitters in rats.
    Jiang H; Li F; Liu S; Sun H; Cui Y; Wu Y
    Neuroscience; 2014 May; 268():112-7. PubMed ID: 24657461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.